
Saudi Arabia Partners with Paradromics for Brain-Computer Interface Development
Saudi Arabia's Neom project has partnered with Paradromics, a brain-computer interface (BCI) startup, to advance neurotechnology healthcare. Announced on Neom's website, this strategic partnership will establish a Brain-Computer Interface Center of Excellence within Neom, aiming to spearhead clinical research and BCI-based healthcare in the MENA region.
Paradromics, known for its high-data rate BCI technology, plans to use this collaboration to develop therapies that restore or enhance neurological functions. The company is set to begin human clinical trials in the US this year, with potential expansion to Saudi Arabia. The partnership is part of Neom's broader strategy to invest in transformative technologies and redefine the future of healthcare.
The collaboration comes amid Saudi Arabia's efforts to diversify its economy and invest in innovative technologies. Paradromics' initial focus is on restoring communication for individuals with conditions like spinal cord injuries and ALS, with future applications targeting mental health treatments.
We hope you enjoyed this article.
Consider subscribing to one of several newsletters we publish like AI Policy Brief.
Also, consider following our LinkedIn page AI Safety & Regulation.
More from: Regulation
More from: Healthcare & Life Sciences
Constitution Billing Partners with Milagro for AI-Driven Coding
Google Cloud and Ai2 Invest $20M in Cancer AI Research
NUS Researchers Use AI and 3D Bioprinting for Personalized Dental Grafts
Mount Sinai Launches AI-Driven Drug Discovery Center
Therapixel and Onsite Women's Health Partner to Deploy AI for Breast Cancer Detection
Subscribe to Daily AI Brief
Daily report covering major AI developments and industry news, with both top stories and complete market updates